INGHAM COUNTY— After the CDC, the FDA and other federal health agencies recommended the immediate halting of administering the Johnson & Johnson vaccine on Tuesday, both Michigan State University, and the Ingham County Health Department have announced that they will no longer be issuing the vaccine in the immediate future.

“Safety is our highest priority. It is important that the CDC and the FDA take time to investigate these rare but serious adverse events,” Ingham County Health Officer Linda S. Vail said. “The pause is a sign that our vaccine reporting and investigation systems are working to ensure safety. It is a sign that the CDC and the FDA are exercising extreme caution with the vaccines. ICHD will await their investigation before taking further action.”

On Tuesday, it was announced that the FDA and the CDC were advising for the immediate stoppage of distributing the Johnson & Johnson vaccine after it was revealed that six people who received the vaccine developed blood clots, as well as low platelet counts. The six reported cases all occurred amongst women between the ages of 18-48, and the severe symptoms arose six to 13 days after the initial injection.

Over 6.8 million doses of the Johnson & Johnson vaccine have been administered since it received emergency use authorization by the FDA on February 27.

The CDC is scheduled to review these cases alongside the Advisory Committee on Immunization Practices on Wednesday, April 14 to determine if any additional precautions need to be issued.

Both the two-dose Pfizer and Moderna vaccines will be used by the Ingham County Health Department as it continues to ramp up vaccination efforts. Michigan State, meanwhile, will be using the Pfizer vaccine as students continue to get vaccinated at the MSU Pavilion for Agriculture and Livestock Education.